Thus, ERO1A-disrupted tumor cells may not be able to resolve the ER stress due to impaired activation of the IRE1α pathway, resulting in an imbalance between the IRE1α activity and PERK activation that governs cell fate.23 The gene discussed is ERO1A; the disease is neoplasm.